Email Updates

Search form

You are here

AVAC's Blog: P-Values

  • Just ahead of another World AIDS Day, two new efficacy trials officially launched in Africa today with the potential of additional HIV prevention methods in the future.

    November 30, 2017
  • ICASA 2017 is coming right up, and AVAC will be there along with many of our partners participating in sessions both before and during the conference. There are several ways you can link to HIV prevention research and rollout-related events—both in-person and from afar.

    November 29, 2017
  • We are excited to share with you our new episode of Px Pulse, AVAC’s podcast covering vital topics in HIV prevention research. This month, we look at the standard of care in HIV prevention trials in the era of oral PrEP. This issue has been discussed and hotly debated lately—and for good reason: It’s complicated.

    November 27, 2017
  • AVAC’s newest issue of Px Wire is coming to you at a critical moment. We’re sharing our recommendations to the US National Institutes of Health’s Division of AIDS (DAIDS), which is in the final days of accepting comments before it begins the process of restructuring the clinical trials networks responsible for a large share of the world’s HIV research.

    November 22, 2017
  • Even close readers of the Weekly NewsDigest may be surprised to know that we are closing in on 18 years of weekly updates. Much has changed over these years – the HIV prevention news itself, the media world, and the technologies that help us compile and edit each issue. But there has always been one constant – the remarkable Polly Harrison!

    November 3, 2017
  • In this second webinar in a series with Dr. Carl Dieffenbach, the Director of the Division of AIDS (DAIDS) at the NIH’s National Institute of Allergy and Infectious Diseases, we discussed the future of investments in the NIH HIV clinical trial research networks in the US and internationally.

    October 27, 2017
  • In this webinar, colleagues from the Treatment Action Group (TAG), along with advocates, researchers and GPP practitioners, discussed the recommendations from the TAG's recently released white paper, HIV Research in the Era of PrEP: The Implications of TDF/FTC for Biomedical Prevention Trials.

    October 26, 2017
  • “You [advocates] push us as hard as you can. It’s your job, and you’re always mad,” said Carl Dieffenbach, Director of NIH’s Division of AIDS (DAIDS), who oversees a global HIV/AIDS research portfolio of more than US$1 billion. “And we’re always failing but in the end, there’s success. Keep pushing.”

    October 17, 2017
    Cindra Feuer
  • Please join AVAC and partners for two upcoming webinars on Thursday, October 26 and Friday, October 27. Thursday’s webinar is in partnership with the Treatment Action Group (TAG) and offers a chance to discuss the role of PrEP in HIV prevention trials. Friday’s webinar is with Dr. Carl Dieffenbach and provides an additional opportunity to talk about the focus and priorities for the NIH-funded HIV clinical trial networks.

    October 16, 2017
  • AVAC is testing a new way to bring you information and updates! Today we are introducing a podcast, Px Pulse, where advocates, researchers, policy makers and community stakeholders can hear from each other about HIV prevention research.

    October 12, 2017